Nucleo Longevity

TMG (Betaine)

TMG · trimethylglycine · betaine · betaine anhydrous

A methyl donor used to lower homocysteine and often paired with NMN/NR.

TypeSupplement / dietary

The grade answers: What does the human evidence support for: Methylation & homocysteine support?

Grade

C

Limited

The grade rates evidence quality — it is not advice to take or buy.

Class
Methyl donor
Primary use
Methylation & homocysteine support
Evidence strength
medium
Last reviewed
2026-07-01

Bottom line

Reliably lowers homocysteine and has some sports-performance data — but whether that translates to longevity, or is even needed alongside NAD boosters, is unproven.

What the evidence says

Betaine (trimethylglycine) is a well-established methyl donor: it dependably lowers blood homocysteine, and there is reasonable evidence for small strength/power benefits in athletes. Its popularity in longevity stacks comes from a theory that NAD⁺ precursors like NMN consume methyl groups, so TMG 'replaces' them — a plausible idea that hasn't actually been shown to matter for outcomes in humans. High-dose betaine can also raise LDL/total cholesterol. Grade C: proven biochemical effect (homocysteine), unproven longevity payoff, with a lipid caveat.

Key studies

  1. [1]

    Betaine and homocysteine · meta-analysis

    Reliable homocysteine lowering.

    Open on PubMed
  2. [2]

    Betaine and exercise performance · review

    Small strength/power signals.

    Open on PubMed
  3. [3]

    Betaine and blood lipids · RCT

    High doses may raise LDL/total cholesterol.

    Open on PubMed
See all studies on PubMed

Mechanism

Donates methyl groups to convert homocysteine back to methionine (an alternative to the folate/B12 pathway), supporting methylation reactions throughout the body.

Safety

Generally well tolerated; GI upset at higher doses. Notably, high-dose betaine has raised total and LDL cholesterol in some trials — relevant given the cardiovascular framing. Not a purely 'free' addition.

Dosage context

Homocysteine/performance trials use ~1.5–6 g/day; longevity-stack use is often ~500–1000 mg to 'offset' NAD-precursor methylation — a dose based on theory, not outcome data.

Examples of application

  • Taken ~500–1000 mg to 'offset' NAD-precursor methylation (a theory).
  • Or ~1.5–6 g/day where homocysteine lowering is the goal.
  • Watched for a possible LDL rise at higher doses.

From the field

TMG is sold as the automatic partner to NMN. The homocysteine effect is real; the 'you must take it with your NAD booster' claim is theory, and the LDL signal is the part that gets left out. Grade C.

Related molecules